Joel Gallant

Type: Person
Name: Joel Gallant
First reported 3 hours ago - Updated 3 hours ago - 1 reports

ICAAC 2014: Cobicistat Long-term Efficacy Matches Ritonavir as PI Booster

Details Category: Experimental HIV Drugs Published on Tuesday, 16 September 2014 00:00 Written by Liz HighleymanLong-term rates of viral suppression and side effects were among people using cobicistat and those using ritonavir as a booster for atazanavir ... [Published HIV and Hepatitis.com - 3 hours ago]
First reported Sep 12 2014 - Updated Sep 12 2014 - 1 reports

Community Leaders, HIV Doctors Oppose Hepatitis C Treatment Barriers

Details Category: HCV Policy & Advocacy Published on Friday, 12 September 2014 00:00 Written by HIVandHepatitis.comA coalition of hepatitis C advocacy organizations and medical providers has issued an open letter to the Secretary of Health and Human ... [Published HIV and Hepatitis.com - Sep 12 2014]
First reported Sep 09 2014 - Updated Sep 09 2014 - 1 reports

IDSA, HIVMA Call for State Medicaid Programs to Lift Hepatitis C Prescribing Restrictions from ID and HIV Doctors

Statement from IDSA President Barbara Murray, MD, FIDSA, andHIVMA Chair Joel Gallant, MD, MPH, FIDSAAt a time when curative treatment is available for hepatitis C (HCV), some state Medicaid programs are instituting harmful barriers to the new HCV treatment, ... [Published Infectious Diseases Society of America - Sep 09 2014]
First reported Sep 04 2014 - Updated Sep 04 2014 - 1 reports

HIV medical organizations challenge insurer restrictions to HCV treatment

Facebook Twitter Google + Email PrintWASHINGTON, DC  – The American Academy of HIV Medicine (AAHIVM) and the HIV Medicine Association (HIVMA), the two largest professional associations representing HIV clinicians in the U.S., are challenging new health ... [Published Project Inform - Sep 04 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

The Role of Triumeq in HIV Treatment

Joel Gallant, M.D., M.P.H.The approval of Triumeq, the single-tablet coformulation of abacavir , lamivudine and the integrase inhibitor dolutegravir, is an important step forward for antiretroviral therapy. All of the previously approved single-tablet ... [Published The Body - Aug 26 2014]
First reported Aug 22 2014 - Updated Aug 23 2014 - 1 reports

Triumeq (Tivicay + Epzicom) Becomes Newest Single-Pill HIV Treatment Regimen

Triumeq becomes the fourth FDA-approved, all-in-one combination HIV treatment regimen, alongside Atripla, Complera and Stribild. Like its three counterparts, Triumeq consists of two nucleoside inhibitors and one or two drugs in other classes. Like Stribild, ... [Published The Body PRO - Aug 22 2014]
Entities: Epzicom, Tivicay, HIV/AIDS

Quotes

...HIV do not die from AIDS-related illness, but from other conditions, including liver disease," said HIVMA chair and HIV specialist Joel Gallant. "many people coinfected with hiv and hcv have been waiting a long time for more effective and tolerable hcv treatment. now that a cure is available, it is unconscionable to deny them access to medical providers who are well qualified to administer and manage this treatment."

More Content

All (7) | News (7) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
ICAAC 2014: Cobicistat Long-term Efficacy Match... [Published HIV and Hepatitis.com - 3 hours ago]
Community Leaders, HIV Doctors Oppose Hepatitis... [Published HIV and Hepatitis.com - Sep 12 2014]
IDSA, HIVMA Call for State Medicaid Programs to... [Published Infectious Diseases Society of America - Sep 09 2014]
IDSA, HIVMA Call for State Medicaid Programs to... [Published Infection Control Today - Sep 09 2014]
HIV medical organizations challenge insurer res... [Published Project Inform - Sep 04 2014]
The Role of Triumeq in HIV Treatment [Published The Body - Aug 26 2014]
Triumeq (Tivicay + Epzicom) Becomes Newest Sing... [Published The Body PRO - Aug 22 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.